These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 8635580)

  • 1. Attempts to convert chymotrypsin to trypsin.
    Venekei I; Szilágyi L; Gráf L; Rutter WJ
    FEBS Lett; 1996 Jan; 379(2):143-7. PubMed ID: 8635580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Attempts to convert chymotrypsin to trypsin.
    Venekei I; Szilágyi L; Gráf L; Rutter WJ
    FEBS Lett; 1996 Mar; 383(1-2):143-7. PubMed ID: 8612781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Converting trypsin to chymotrypsin: structural determinants of S1' specificity.
    Kurth T; Ullmann D; Jakubke HD; Hedstrom L
    Biochemistry; 1997 Aug; 36(33):10098-104. PubMed ID: 9254605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trypsin: a case study in the structural determinants of enzyme specificity.
    Hedstrom L
    Biol Chem; 1996; 377(7-8):465-70. PubMed ID: 8922280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crystal structure of cancer chemopreventive Bowman-Birk inhibitor in ternary complex with bovine trypsin at 2.3 A resolution. Structural basis of Janus-faced serine protease inhibitor specificity.
    Koepke J; Ermler U; Warkentin E; Wenzl G; Flecker P
    J Mol Biol; 2000 May; 298(3):477-91. PubMed ID: 10772864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Three dimensional structures of S189D chymotrypsin and D189S trypsin mutants: the effect of polarity at site 189 on a protease-specific stabilization of the substrate-binding site.
    Szabó E; Venekei I; Böcskei Z; Náray-Szabó G; Gráf L
    J Mol Biol; 2003 Aug; 331(5):1121-30. PubMed ID: 12927546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crystal structures of bovine chymotrypsin and trypsin complexed to the inhibitor domain of Alzheimer's amyloid beta-protein precursor (APPI) and basic pancreatic trypsin inhibitor (BPTI): engineering of inhibitors with altered specificities.
    Scheidig AJ; Hynes TR; Pelletier LA; Wells JA; Kossiakoff AA
    Protein Sci; 1997 Sep; 6(9):1806-24. PubMed ID: 9300481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predicted three-dimensional structural models of venom serine protease inhibitors and their interactions with trypsin and chymotrypsin.
    Azim MK; Grossmann JG; Zaidi ZH
    J Nat Toxins; 1999 Oct; 8(3):363-84. PubMed ID: 10591040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Converting trypsin to chymotrypsin: the role of surface loops.
    Hedstrom L; Szilagyi L; Rutter WJ
    Science; 1992 Mar; 255(5049):1249-53. PubMed ID: 1546324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel substrate-binding pocket interaction restricts the specificity of the human NK cell-specific serine protease, Met-ase-1.
    Smyth MJ; O'Connor MD; Trapani JA; Kershaw MH; Brinkworth RI
    J Immunol; 1996 Jun; 156(11):4174-81. PubMed ID: 8666785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Converting trypsin to chymotrypsin: residue 172 is a substrate specificity determinant.
    Hedstrom L; Perona JJ; Rutter WJ
    Biochemistry; 1994 Jul; 33(29):8757-63. PubMed ID: 8038165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crystal structure of bovine duodenase, a serine protease, with dual trypsin and chymotrypsin-like specificities.
    Pletnev VZ; Zamolodchikova TS; Pangborn WA; Duax WL
    Proteins; 2000 Oct; 41(1):8-16. PubMed ID: 10944388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ala226 to Gly and Ser189 to Asp mutations convert rat chymotrypsin B to a trypsin-like protease.
    Jelinek B; Antal J; Venekei I; Gráf L
    Protein Eng Des Sel; 2004 Feb; 17(2):127-31. PubMed ID: 15047908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specificity of trypsin and chymotrypsin: loop-motion-controlled dynamic correlation as a determinant.
    Ma W; Tang C; Lai L
    Biophys J; 2005 Aug; 89(2):1183-93. PubMed ID: 15923233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thermodynamic criterion for the conformation of P1 residues of substrates and of inhibitors in complexes with serine proteinases.
    Qasim MA; Lu SM; Ding J; Bateman KS; James MN; Anderson S; Song J; Markley JL; Ganz PJ; Saunders CW; Laskowski M
    Biochemistry; 1999 Jun; 38(22):7142-50. PubMed ID: 10353824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of disulfide bond C191-C220 in trypsin and chymotrypsin.
    Várallyay E; Lengyel Z; Gráf L; Szilágyi L
    Biochem Biophys Res Commun; 1997 Jan; 230(3):592-6. PubMed ID: 9015368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alanine point-mutations in the reactive region of bovine pancreatic trypsin inhibitor: effects on the kinetics and thermodynamics of binding to beta-trypsin and alpha-chymotrypsin.
    Castro MJ; Anderson S
    Biochemistry; 1996 Sep; 35(35):11435-46. PubMed ID: 8784199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molluscan chymotrypsin-like protease: structure, localization, and substrate specificity.
    Groppe JC; Morse DE
    Arch Biochem Biophys; 1993 Aug; 305(1):159-69. PubMed ID: 8342947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contribution to activity of histidine-aromatic, amide-aromatic, and aromatic-aromatic interactions in the extended catalytic site of cysteine proteinases.
    Brömme D; Bonneau PR; Purisima E; Lachance P; Hajnik S; Thomas DY; Storer AC
    Biochemistry; 1996 Apr; 35(13):3970-9. PubMed ID: 8672429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural origins of substrate discrimination in trypsin and chymotrypsin.
    Perona JJ; Hedstrom L; Rutter WJ; Fletterick RJ
    Biochemistry; 1995 Feb; 34(5):1489-99. PubMed ID: 7849008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.